WHO Endorses Cepheid's TB Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The World Health Organization today endorsed Cepheid's Xpert MTB/RIF test for rapid testing of tuberculosis, calling it "a major milestone for global TB diagnosis and care."

WHO is now calling for the fully-automated nucleic acid amplification test to be rolled out under defined conditions as part of national plans for TB and multi-drug resistant TB care and control.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."